Neuroprotective Effects of Lamiaceae-Derived Plant Extracts in Murine Models of Anxiety and Depression: A Systematic Review and Meta-Analysis
Authors:
- Welton Aaron de AlmeidaWAWelton Aaron de Almeida
- Emmanuel Viana PontualEmmanuel Viana Pontual
- Lucas Gabriel Pita dos SantosLSLucas Gabriel Pita dos Santos
- Thiago Henrique NapoleãoThiago Henrique Napoleão
- Leydianne Leite de Siqueira PatriotaLPLeydianne Leite de Siqueira Patriota
- Rafael de Freitas e SilvaRSRafael de Freitas e Silva
Open Access
- 10 November 2026
- journal article
- review article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 94 (4) , 110
Abstract
Anxiety and depression are prevalent neuropsychiatric disorders, and Lamiaceae species have shown neuroprotective and psychotropic properties. However, no systematic review with quantitative synthesis has specifically assessed phytochemically characterized Lamiaceae extracts in preclinical models of these disorders. This study reviewed and meta-analyzed the available evidence following PRISMA 2020 guidelines. Searches of EMBASE, MEDLINE, ScienceDirect, Scopus, and Web of Science through May 2026 identified controlled studies evaluating phytochemically characterized whole-plant extracts. Risk of bias was assessed using SYRCLE, and random-effects meta-analyses with the Knapp–Hartung adjustment were performed. Nine studies met the inclusion criteria. A significant anxiolytic-like effect was observed in the Open Field Test (SMD = 2.81, 95% CI: 1.37–4.24; k = 3), whereas Elevated Plus Maze and Hole-Board Test results favored treatment but were not statistically significant. For depression-like behavior, immobility was reduced in the Tail Suspension Test (TST; SMD = −2.44, 95% CI: −3.09 to −1.79; k = 3). However, this result was sensitive to sex-based data selection: substituting male for female offspring data from one study rendered the effect non-significant and introduced substantial heterogeneity. The primary Forced Swimming Test (FST) analysis was also non-significant (SMD = −3.75, 95% CI: −8.01 to 0.52; k = 8), with a significant reduction in immobility observed only after excluding a highly influential study (SMD = −1.73, 95% CI: −2.49 to −0.97; k = 7). Reported biological effects included antioxidant, neuroprotective, and neuromodulatory actions involving GABAergic, serotonergic, cholinergic, and neurotrophic pathways. Given the small number of studies, imprecise estimates, and incomplete methodological reporting, these findings suggest rather than establish the therapeutic potential of phytochemically characterized Lamiaceae extracts. Further studies using standardized protocols are needed to strengthen the evidence and support translational research.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (407192/2018-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (408789/2016–6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (151206/2024-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (APQ-0108-2.08-14)
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (APQ-1324-2.08/22)
This publication has 24 references indexed in Scilit:
- Sedative-hypnotic, anxiolytic and possible side effects of Salvia limbata C. A. Mey. Extracts and the effects of phenological stage and altitude on the rosmarinic acid contentJournal of Ethnopharmacology, 2022
- Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant ActionBiological Psychiatry, 2021
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisThe Lancet, 2018
- Investigation of in vitro thrombolytic and anti-helminthic activity and in vivo anxiolytic and antidepressant potentiality with phytochemical nature of methanolic extract of Leucas lavandulifoliaSustainable Chemistry and Pharmacy, 2017
- A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitterJournal of Ethnopharmacology, 2015
- Rosemary tea consumption results to anxiolytic- and anti-depressant-like behavior of adult male mice and inhibits all cerebral area and liver cholinesterase activity; phytochemical investigation and in silico studiesChemico-Biological Interactions, 2015
- Animal models of neuropsychiatric disordersNature Neuroscience, 2010
- The neuroprotective potential of flavonoids: a multiplicity of effectsGenes & Nutrition, 2008
- Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic applicationPharmacology & Therapeutics, 2006
- The ascent of mouse: advances in modelling human depression and anxietyNature Reviews Drug Discovery, 2005